FATE
Fate Therapeutics Inc.
$1.03
+$0.03(+3.00%)
39
Overall
60
Value
18
Tech
--
Quality
Market Cap
$137.24M
Volume
1.07M
52W Range
$0.66 - $3.43
Target Price
$4.65
EPS Estimates Overview
| Current Quarter | $-0.29 | Next Quarter | $-0.32 |
| Current Year | $-1.14 | Next Year | $-1.18 |
| QoQ Growth | -10.3% | YoY Growth | -3.5% |
| 3Y EPS CAGR | +9.9% | Target Price | $4.65 |
| Consensus | Buy | Upside | +351.5% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | FATE | $1.03 | +3.0% | 1.07M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |